ID   GNAI2_RAT               Reviewed;         355 AA.
AC   P04897;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   20-JUN-2018, entry version 166.
DE   RecName: Full=Guanine nucleotide-binding protein G(i) subunit alpha-2;
DE   AltName: Full=Adenylate cyclase-inhibiting G alpha protein;
GN   Name=Gnai2; Synonyms=Gnai-2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha;
OC   Muroidea; Muridae; Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3086867; DOI=10.1073/pnas.83.11.3776;
RA   Itoh H., Kozasa T., Nagata S., Nakamura S., Katada T., Ui M., Iwai S.,
RA   Ohtsuka E., Kawasaki H., Suzuki K., Kaziro Y.;
RT   "Molecular cloning and sequence determination of cDNAs for alpha
RT   subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go
RT   from rat brain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:3776-3780(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2820999;
RA   Jones D.T., Reed R.R.;
RT   "Molecular cloning of five GTP-binding protein cDNA species from rat
RT   olfactory neuroepithelium.";
RL   J. Biol. Chem. 262:14241-14249(1987).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   PROTEIN SEQUENCE OF 12-126.
RX   PubMed=2159473;
RA   Linder M.E., Ewald D.A., Miller R.J., Gilman A.G.;
RT   "Purification and characterization of Go alpha and three types of Gi
RT   alpha after expression in Escherichia coli.";
RL   J. Biol. Chem. 265:8243-8251(1990).
RN   [5]
RP   INTERACTION WITH GPSM1.
RX   PubMed=11121039; DOI=10.1073/pnas.97.26.14364;
RA   de Vries L., Fischer T., Tronchere H., Brothers G.M., Strockbine B.,
RA   Siderovski D.P., Farquhar M.G.;
RT   "Activator of G protein signaling 3 is a guanine dissociation
RT   inhibitor for Galpha i subunits.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:14364-14369(2000).
RN   [6]
RP   INTERACTION WITH RGS12 AND RGS14.
RX   PubMed=11387333; DOI=10.1074/jbc.M103208200;
RA   Kimple R.J., De Vries L., Tronchere H., Behe C.I., Morris R.A.,
RA   Gist Farquhar M., Siderovski D.P.;
RT   "RGS12 and RGS14 GoLoco motifs are G alpha(i) interaction sites with
RT   guanine nucleotide dissociation inhibitor activity.";
RL   J. Biol. Chem. 276:29275-29281(2001).
RN   [7]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16870394; DOI=10.1016/j.cellsig.2006.06.002;
RA   Shu F.J., Ramineni S., Amyot W., Hepler J.R.;
RT   "Selective interactions between Gi alpha1 and Gi alpha3 and the
RT   GoLoco/GPR domain of RGS14 influence its dynamic subcellular
RT   localization.";
RL   Cell. Signal. 19:163-176(2007).
RN   [8]
RP   MUTAGENESIS OF MET-82; VAL-85; LYS-86; ASN-90; GLN-92; ALA-96; PRO-98;
RP   GLN-99; SER-111; CYS-112; PRO-121 AND GLU-122.
RX   PubMed=15337739; DOI=10.1074/jbc.M407409200;
RA   Mittal V., Linder M.E.;
RT   "The RGS14 GoLoco domain discriminates among Galphai isoforms.";
RL   J. Biol. Chem. 279:46772-46778(2004).
RN   [9]
RP   SUBCELLULAR LOCATION.
RX   PubMed=17635935; DOI=10.1083/jcb.200604114;
RA   Cho H., Kehrl J.H.;
RT   "Localization of Gi alpha proteins in the centrosomes and at the
RT   midbody: implication for their role in cell division.";
RL   J. Cell Biol. 178:245-255(2007).
CC   -!- FUNCTION: Guanine nucleotide-binding proteins (G proteins) are
CC       involved as modulators or transducers in various transmembrane
CC       signaling systems. The G(i) proteins are involved in hormonal
CC       regulation of adenylate cyclase: they inhibit the cyclase in
CC       response to beta-adrenergic stimuli. May play a role in cell
CC       division.
CC   -!- SUBUNIT: G proteins are composed of 3 units; alpha, beta and
CC       gamma. The alpha chain contains the guanine nucleotide binding
CC       site. Interacts with UNC5B (By similarity). Interacts with GPSM1.
CC       Interacts with RGS12 and RGS14. {ECO:0000250,
CC       ECO:0000269|PubMed:11121039, ECO:0000269|PubMed:11387333}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell membrane.
CC       Cytoplasm, cytoskeleton, microtubule organizing center,
CC       centrosome. Membrane {ECO:0000250|UniProtKB:P04899}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:P04899}. Note=Localizes in the centrosomes
CC       of interphase and mitotic cells. Detected at the cleavage furrow
CC       and/or the midbody (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the G-alpha family. G(i/o/t/z) subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M12672; AAA41260.1; -; mRNA.
DR   EMBL; M17528; AAA40824.1; -; mRNA.
DR   EMBL; BC078806; AAH78806.1; -; mRNA.
DR   PIR; D27423; RGRTI2.
DR   RefSeq; NP_112297.1; NM_031035.3.
DR   RefSeq; XP_006243920.1; XM_006243858.1.
DR   UniGene; Rn.3036; -.
DR   ProteinModelPortal; P04897; -.
DR   SMR; P04897; -.
DR   BioGrid; 249564; 2.
DR   CORUM; P04897; -.
DR   DIP; DIP-607N; -.
DR   IntAct; P04897; 2.
DR   STRING; 10116.ENSRNOP00000022550; -.
DR   iPTMnet; P04897; -.
DR   PhosphoSitePlus; P04897; -.
DR   SwissPalm; P04897; -.
DR   PaxDb; P04897; -.
DR   PRIDE; P04897; -.
DR   Ensembl; ENSRNOT00000022550; ENSRNOP00000022550; ENSRNOG00000016592.
DR   GeneID; 81664; -.
DR   KEGG; rno:81664; -.
DR   UCSC; RGD:620243; rat.
DR   CTD; 2771; -.
DR   RGD; 620243; Gnai2.
DR   eggNOG; KOG0082; Eukaryota.
DR   eggNOG; ENOG410XNVQ; LUCA.
DR   GeneTree; ENSGT00760000118851; -.
DR   HOGENOM; HOG000038730; -.
DR   HOVERGEN; HBG063184; -.
DR   InParanoid; P04897; -.
DR   KO; K04630; -.
DR   OMA; EQGIMPD; -.
DR   OrthoDB; EOG091G0VUT; -.
DR   PhylomeDB; P04897; -.
DR   TreeFam; TF300673; -.
DR   Reactome; R-RNO-112043; PLC beta mediated events.
DR   Reactome; R-RNO-170670; Adenylate cyclase inhibitory pathway.
DR   Reactome; R-RNO-202040; G-protein activation.
DR   Reactome; R-RNO-392170; ADP signalling through P2Y purinoceptor 12.
DR   Reactome; R-RNO-400042; Adrenaline,noradrenaline inhibits insulin secretion.
DR   Reactome; R-RNO-418594; G alpha (i) signalling events.
DR   Reactome; R-RNO-6814122; Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding.
DR   SABIO-RK; P04897; -.
DR   PRO; PR:P04897; -.
DR   Proteomes; UP000002494; Chromosome 8.
DR   Bgee; ENSRNOG00000016592; -.
DR   ExpressionAtlas; P04897; baseline and differential.
DR   Genevisible; P04897; RN.
DR   GO; GO:0044297; C:cell body; IEA:Ensembl.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:RGD.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0005834; C:heterotrimeric G-protein complex; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; IDA:RGD.
DR   GO; GO:0045121; C:membrane raft; IDA:RGD.
DR   GO; GO:0030496; C:midbody; ISS:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0031683; F:G-protein beta/gamma-subunit complex binding; IBA:GO_Central.
DR   GO; GO:0001664; F:G-protein coupled receptor binding; IBA:GO_Central.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0001973; P:adenosine receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007189; P:adenylate cyclase-activating G-protein coupled receptor signaling pathway; IMP:RGD.
DR   GO; GO:0007193; P:adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell proliferation; IEA:Ensembl.
DR   GO; GO:0007213; P:G-protein coupled acetylcholine receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007186; P:G-protein coupled receptor signaling pathway; IDA:RGD.
DR   GO; GO:0007214; P:gamma-aminobutyric acid signaling pathway; IDA:RGD.
DR   GO; GO:0140199; P:negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process; IDA:RGD.
DR   GO; GO:2001234; P:negative regulation of apoptotic signaling pathway; IMP:RGD.
DR   GO; GO:0045955; P:negative regulation of calcium ion-dependent exocytosis; IMP:RGD.
DR   GO; GO:1903614; P:negative regulation of protein tyrosine phosphatase activity; IMP:RGD.
DR   GO; GO:0050805; P:negative regulation of synaptic transmission; IDA:RGD.
DR   GO; GO:0030335; P:positive regulation of cell migration; IMP:RGD.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IMP:RGD.
DR   GO; GO:0070374; P:positive regulation of ERK1 and ERK2 cascade; IMP:RGD.
DR   GO; GO:0046628; P:positive regulation of insulin receptor signaling pathway; IMP:RGD.
DR   GO; GO:0033864; P:positive regulation of NAD(P)H oxidase activity; IMP:RGD.
DR   GO; GO:2000179; P:positive regulation of neural precursor cell proliferation; IMP:RGD.
DR   GO; GO:0035815; P:positive regulation of renal sodium excretion; IMP:RGD.
DR   GO; GO:0032930; P:positive regulation of superoxide anion generation; IMP:RGD.
DR   GO; GO:0035810; P:positive regulation of urine volume; IMP:RGD.
DR   GO; GO:1904707; P:positive regulation of vascular smooth muscle cell proliferation; IMP:RGD.
DR   GO; GO:0051924; P:regulation of calcium ion transport; IDA:RGD.
DR   CDD; cd00066; G-alpha; 1.
DR   Gene3D; 1.10.400.10; -; 1.
DR   InterPro; IPR001408; Gprotein_alpha_I.
DR   InterPro; IPR001019; Gprotein_alpha_su.
DR   InterPro; IPR011025; GproteinA_insert.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR10218; PTHR10218; 1.
DR   Pfam; PF00503; G-alpha; 1.
DR   PRINTS; PR00318; GPROTEINA.
DR   PRINTS; PR00441; GPROTEINAI.
DR   SMART; SM00275; G_alpha; 1.
DR   SUPFAM; SSF47895; SSF47895; 1.
DR   SUPFAM; SSF52540; SSF52540; 2.
PE   1: Evidence at protein level;
KW   Cell cycle; Cell division; Cell membrane; Complete proteome;
KW   Cytoplasm; Cytoskeleton; Direct protein sequencing; GTP-binding;
KW   Lipoprotein; Magnesium; Membrane; Metal-binding; Myristate;
KW   Nucleotide-binding; Palmitate; Polymorphism; Reference proteome;
KW   Transducer.
FT   INIT_MET      1      1       Removed. {ECO:0000250|UniProtKB:P04899}.
FT   CHAIN         2    355       Guanine nucleotide-binding protein G(i)
FT                                subunit alpha-2.
FT                                /FTId=PRO_0000203682.
FT   NP_BIND      40     47       GTP. {ECO:0000250}.
FT   NP_BIND     176    182       GTP. {ECO:0000250}.
FT   NP_BIND     201    205       GTP. {ECO:0000250}.
FT   NP_BIND     270    273       GTP. {ECO:0000250}.
FT   METAL        47     47       Magnesium. {ECO:0000250}.
FT   METAL       182    182       Magnesium. {ECO:0000250}.
FT   BINDING     327    327       GTP; via amide nitrogen. {ECO:0000250}.
FT   LIPID         2      2       N-myristoyl glycine.
FT                                {ECO:0000250|UniProtKB:P04899}.
FT   LIPID         3      3       S-palmitoyl cysteine. {ECO:0000250}.
FT   VARIANT     166    167       SD -> PN (in tryptic peptides).
FT   MUTAGEN      82     82       M->I: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                85; R-86; R-90; K-92; G-96; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with I-85 and
FT                                A-111. {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      85     85       V->I: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; R-86; R-90; K-92; G-96; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with I-82 and
FT                                A-111. {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      86     86       K->R: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-90; K-92; G-96; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      90     90       N->R: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; K-92; G-96; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      92     92       Q->K: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; G-96; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      96     96       A->G: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; A-98; A-99;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      98     98       P->A: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-99;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN      99     99       Q->A: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-111; G-112; T-121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN     111    111       S->A: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-99; G-112; T-121 and A-122. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with G-112; T-
FT                                121 and A-122. Does not increase
FT                                sensitivity to RGS14 GTPase activity;
FT                                when associated with I-82 and A-85.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN     112    112       C->G: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-99; A-111; T-121 and A-122. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with G-111; T-
FT                                121 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN     117    117       Missing: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-99; A-111; G-112; T-121 and A-122. Does
FT                                not increase sensitivity to RGS14 GTPase
FT                                activity; when associated with G-111; G-
FT                                112; T-121 and A-122.
FT   MUTAGEN     121    121       P->T: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-99; A-111; G-112 and A-122. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with G-111; G-
FT                                112 and A-122.
FT                                {ECO:0000269|PubMed:15337739}.
FT   MUTAGEN     122    122       E->A: Increases sensitivity to RGS14
FT                                GTPase activity; when associated with I-
FT                                82; I-85; R-86; R-90; K-92; G-96; A-98;
FT                                A-99; A-111; G-112 and T-121. Does not
FT                                increase sensitivity to RGS14 GTPase
FT                                activity; when associated with G-111; G-
FT                                112 and T-121.
FT                                {ECO:0000269|PubMed:15337739}.
SQ   SEQUENCE   355 AA;  40499 MW;  9360ABAC6BDC493E CRC64;
     MGCTVSAEDK AAAERSKMID KNLREDGEKA AREVKLLLLG AGESGKSTIV KQMKIIHEDG
     YSEEECRQYR AVVYSNTIQS IMAIVKAMGN LQIDFADPQR ADDARQLFAL SCAAEEQGML
     PEDLSGVIRR LWADHGVQAC FGRSREYQLN DSAAYYLNDL ERIAQSDYIP TQQDVLRTRV
     KTTGIVETHF TFKDLHFKMF DVGGQRSERK KWIHCFEGVT AIIFCVALSA YDLVLAEDEE
     MNRMHESMKL FDSICNNKWF TDTSIILFLN KKDLFEEKIT QSPLTICFPE YTGANKYDEA
     ASYIQSKFED LNKRKDTKEI YTHFTCATDT KNVQFVFDAV TDVIIKNNLK DCGLF
//
